Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Citi
Accenture
US Department of Justice
Cantor Fitzgerald
Boehringer Ingelheim
Julphar
QuintilesIMS
McKinsey
Deloitte

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 005691

« Back to Dashboard

NDA 005691 describes VERTAVIS, which is a drug marketed by Medpointe Pharm Hlc and is included in one NDA. Additional details are available on the VERTAVIS profile page.

The generic ingredient in VERTAVIS is veratrum viride root. There are two drug master file entries for this compound. Additional details are available on the veratrum viride root profile page.
Summary for 005691
Tradename:VERTAVIS
Applicant:Medpointe Pharm Hlc
Ingredient:veratrum viride root
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength130CSR UNIT
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Queensland Health
AstraZeneca
Mallinckrodt
Teva
US Army
Dow
Daiichi Sankyo
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot